Occupational and non-occupational contact
with HIV-containing liquids can lead to a transmission of the HIV-virus. After
the exposure several measures can be taken which reduce the risk of an HIV
transmission.
HIV-PEP
standard therapy
Truvada® (1 x 1) P L U S Kaletra® (2 x 2)
(oder Combivir® (2 x 1) P L U S Kaletra® (2 x 2))
- For information on possible combinations
see the German-Austrian Recommendations on HIV-PEP
- In case of contra-indications against
protease inhibitors Sustiva® is an option (CAVE: not during pregnancy!!)
- Pregnancy: Contra-indication for Sustiva®, PI problematic,
consult an expert
- In case of viruses with many resistances,
Prezista®
or Fuzeon®
are an option
- Time interval between HIV-exposure and
PEP-start:
start of PEP as
early as possible (maximum effect when started within 2 hours of exposure)
reduced
efficacy when started 24 hours till 72 hours after exposition
no
PEP indicated when contact is >72hours ago
- duration of PEP: four weeks
- the mentioned drugs are not approved for PEP
HIV-Postexposure prophylaxis- The newest
recommendations (in German)
PEP-Faltblatt